Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Effect of baseline characteristics on mortality in the SURVIVE trial on the effect of levosimendan vs dobutamine in acute heart failure: Sub-analysis of the Finnish patients.

Kivikko M, Pollesello P, Tarvasmäki T, Sarapohja T, Nieminen MS, Harjola VP.

Int J Cardiol. 2016 Jul 15;215:26-31. doi: 10.1016/j.ijcard.2016.04.064. Epub 2016 Apr 14.

2.

Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation.

Turunen H, Jakob SM, Ruokonen E, Kaukonen KM, Sarapohja T, Apajasalo M, Takala J.

Crit Care. 2015 Feb 19;19:67. doi: 10.1186/s13054-015-0787-y.

3.

Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.

Packer M, Colucci W, Fisher L, Massie BM, Teerlink JR, Young J, Padley RJ, Thakkar R, Delgado-Herrera L, Salon J, Garratt C, Huang B, Sarapohja T; REVIVE Heart Failure Study Group..

JACC Heart Fail. 2013 Apr;1(2):103-11. doi: 10.1016/j.jchf.2012.12.004. Epub 2013 Apr 1.

PMID:
24621834
4.

Population pharmacokinetics of dexmedetomidine in critically ill patients.

Välitalo PA, Ahtola-Sätilä T, Wighton A, Sarapohja T, Pohjanjousi P, Garratt C.

Clin Drug Investig. 2013 Aug;33(8):579-87. doi: 10.1007/s40261-013-0101-1.

5.

Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials.

Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, Bratty JR, Takala J; Dexmedetomidine for Long-Term Sedation Investigators..

JAMA. 2012 Mar 21;307(11):1151-60. doi: 10.1001/jama.2012.304.

PMID:
22436955
6.

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.

Bergh CH, Andersson B, Dahlström U, Forfang K, Kivikko M, Sarapohja T, Ullman B, Wikström G.

Eur J Heart Fail. 2010 Apr;12(4):404-10. doi: 10.1093/eurjhf/hfq032.

7.

Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function.

Eriksson HI, Jalonen JR, Heikkinen LO, Kivikko M, Laine M, Leino KA, Kuitunen AH, Kuttila KT, Peräkylä TK, Sarapohja T, Suojaranta-Ylinen RT, Valtonen M, Salmenperä MT.

Ann Thorac Surg. 2009 Feb;87(2):448-54. doi: 10.1016/j.athoracsur.2008.10.029.

PMID:
19161758
8.

Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.

Nieminen MS, Cleland JG, Eha J, Belenkov Y, Kivikko M, Põder P, Sarapohja T.

Eur J Heart Fail. 2008 Dec;10(12):1246-54. doi: 10.1016/j.ejheart.2008.09.006. Epub 2008 Oct 21.

9.

Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation.

Ruokonen E, Parviainen I, Jakob SM, Nunes S, Kaukonen M, Shepherd ST, Sarapohja T, Bratty JR, Takala J; "Dexmedetomidine for Continuous Sedation" Investigators..

Intensive Care Med. 2009 Feb;35(2):282-90. doi: 10.1007/s00134-008-1296-0. Epub 2008 Sep 16.

PMID:
18795253
10.

The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure.

Harjola VP, Oikarinen L, Toivonen L, Jurkko R, Puttonen J, Sarapohja T, Sundberg S, Nieminen MS.

Int J Clin Pharmacol Ther. 2008 Aug;46(8):389-99.

PMID:
18793580

Supplemental Content

Loading ...
Support Center